TCT-104 Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Transcatheter aortic valve replacement is recommended in inoperable patients with severe, symptomatic aortic stenosis (AS), and is an accepted alternative to surgical AVR in high risk patients. However, increased stroke, bleeding, vascular complications and aortic regurgitation (AR) rates may